跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,507 条关于
“LTI-214”
全部
8,507
临床试验
1,740
药物
2,493
机构
3,802
资讯
472
10个月前
FDA Grants Orphan Drug Designation to Leukogene's M2T-CD33 for Acute Myeloid Leukemia Treatment
去年
Aileron Therapeutics Presents Positive Phase 1b Data for LTI-03 in Idiopathic Pulmonary Fibrosis
去年
Aileron Therapeutics' LTI-03 Shows Promise in Idiopathic Pulmonary Fibrosis Trial
6个月前
AdAlta Completes Global Patent Protection for Anti-Fibrotic Drug AD-214 with Canadian Approval
去年
Vividion Secures Exclusive Rights to First-in-Class WRN Inhibitor VVD-214 for MSI-High Cancers
8个月前
Vividion's WRN Inhibitor VVD-214 Shows Promise for MSI-High Cancers in Journal of Medicinal Chemistry Publication
去年
Long-term CheckMate 214 Data Highlights Need for Biomarkers in Metastatic RCC Treatment Selection
去年
Aileron Therapeutics Rebrands as Rein Therapeutics, Focuses on Fibrosis Therapies
3年前
BIAL R&D Doses First Patient in Phase 2 Trial of BIA 28-6156 for Parkinson's Disease with GBA1 Mutation
去年
Perioperative IO/TKI Combo Shows Promise in Renal Cell Carcinoma
第 1 页,共 48 页
上一页
下一页